TGFB1 and hepatocellular carcinoma: Chronic TGF-β treatment in rat and human fetal hepatocytes, as well as in human HCC cells, promotes a mesenchymal-like phenotype concomitant with decreased expression of specific hepatic genes and the appearance of stem cell features, reminiscent of a progenitor-like phenotype (156, 177, 178).